Articles > Popular publications > PR Newswire press releases > April-June 2005 > Monday, May 23

Article: Multimedia News Release - RAZADYNE(TM) ER, New Once-Daily Treatment Option, Now Available for Patients With Mild to Moderate Alzheimer's Disease.

Article from:
PR Newswire
Article date:
May 23, 2005
Copyright

New Capsule Formulation Allows for Once-Daily Treatment That's Effective and Convenient

TITUSVILLE, N.J., May 23 /PRNewswire/ -- RAZADYNE(TM) ER (galantamine hydrobromide), a new once-daily treatment for the symptoms of mild to moderate Alzheimer's disease, is now available by prescription nationwide. The product is marketed by Ortho-McNeil Neurologics, Inc.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/gymr/21575

Approved by the U.S. Food and Drug Administration (FDA) in December 2004, RAZADYNE ER contains galantamine hydrobromide -- first approved by the FDA in February 2001 as a twice-daily medication, ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Ortho-McNeil Neurologics to Appeal Patent Ruling on ...
PR Newswire;  August 28, 2008 ;     700+ words ... ... PRNewswire/ -- Ortho-McNeil Neurologics, Division of Ortho ... Janssen and Ortho-McNeil Neurologics. "We believe the patent ... case. RAZADYNE and RAZADYNE ER are marketed by Ortho-McNeil Neurologics in the United States ...

Article: Aptilon Announces AxcelRx(SM) Live Video Detailing Sales Channel ...
Business Wire;  September 25, 2007 ;     700+ words ...Ortho-McNeil Neurologics, Inc. Adds Technology-Based ... today announced that Ortho-McNeil Neurologics, Inc. has selected Aptilon ... model that will enable Ortho-McNeil Neurologics representatives to provide convenient ...

Article: U.S. District Court Grants Request for Preliminary Injunction to ...
PR Newswire;  October 24, 2006 ;     685 words ... ... has granted the request of Ortho-McNeil Neurologics, Inc., a subsidiary of Johnson ... in Titusville, N.J., Ortho-McNeil Neurologics, Inc. focuses exclusively on providing ... preventive migraine treatment. Ortho-McNeil Neurologics, Inc., in conjunction with internal ...

ORTHO-MCNEIL NEUROLOGICS EPILEPSY DISCUSSION
AP Images;  March 28, 2008 ;     264 words ... ... supporters on the National Mall on Saturday, March 29, for the Second Annual National Walk for Epilepsy, sponsored by the Epilepsy Foundation in partnership with Ortho-McNeil Neurologics, Inc. (PRNewsFoto/ORTHO-McNEIL NEUROLOGICS)

Article: Ortho-McNeil Neurologics Sponsors Event to Support ...
PR Newswire;  June 8, 2005 ;     700+ words ... ... for the UCLA Center on Aging, chaired the ICON event for the third year. The event was sponsored by Ortho-McNeil Neurologics and produced by EventsbyOne. Founded in 1991, the UCLA Center on Aging is a non-profit organization that aims ...

Article: FDA has ordered Ortho-McNeil Neurologics to change ...
Medical Marketing & Media;  June 1, 2005 ;     584 words ...FDA has ordered Ortho-McNeil Neurologics to change the name of its Alzheimer's therapy Reminyl to Razadyne to avoid prescribing errors with Sanofi-Aventis' diabetes drug Amaryl; and, separately to modify its "Precautions" after 14 patients died in trials.

Article: Topamax receives pediatric ...
Chain Drug Review;  August 18, 2008 ;     576 words ...Topamax has been granted pediatric exclusivity from the Food and Drug Administration. The Ortho-McNeil Neurologics product is indicated as initial monotherapy in patients ages 10 and older with partial-onset seizures. The new FDA designation ...

Article: /C O R R E C T I O N -- Ortho-McNeil Neurologics, ...
PR Newswire;  March 22, 2007 ;     345 words ... ... Injunction Prohibiting Mylan from Marketing Generic Version of TOPAMAX(R), issued earlier today by Ortho-McNeil Neurologics, Inc. over PR Newswire, we are advised by a representative of the company that the fourth paragraph, first ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives